New patent granted to Lycored for composition combining omega-3 fatty acids with lycopene
Lycored will be developing a new formulation combining its Lycomato lycopene with omega-3 fatty acids.
Photo © iStockphoto.com/fotokostic
Lycored (Secaucus, NJ) has announced that it has been granted a U.S. patent for a composition comprising omega-3 fatty acid with patented tomato extract lycopene, Lycomato, and optionally with carnosic acid and or/lutein. The combination has been found to work synergistically to support healthy inflammation in the body, inhibiting inflammatory markers by suppressing anti-inflammatory mediators, says the company. Lycored recently published a study in NeuroMolecular Medicine demonstrating the combination’s ability to balance inflammatory markers in the brain.
“Lycored is currently in the process of developing a new formulation that directly addresses the components of this new patent, which would enhance the use of existing omega-3 products, and benefits to inflammatory markers that support overall brain health,” said Karin Hermoni, PhD, head of science and nutrition at Lycored, in a press release. “This patent is a milestone in Lycored’s plan program for developing innovative solutions for brain health, and we are excited to implement this new patent into our already extensive portfolio.”
Brightseed launches clinically validated ingredient, Bio Gut Core, to support gut barrier function
May 21st 2025The low-dose, easy-to-formulate ingredient is a proprietary blend of two bioactives – N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT) – which were discovered by the company’s Forage AI platform.
A country-by-country blueprint for nutraceutical success in Europe
May 20th 2025The European nutraceutical market is growing rapidly, but the continent is not a monolith when it comes to consumer trends and product innovation. This article is a blue-print for what nutraceutical success looks like in different European countries.
